What is the treatment protocol for conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Protocol for Conjunctivitis

Bacterial Conjunctivitis

For mild to moderate bacterial conjunctivitis, prescribe a 5-7 day course of broad-spectrum topical antibiotic applied 4 times daily, which accelerates clinical resolution, reduces transmissibility, and allows earlier return to school or work. 1

First-Line Antibiotic Selection

  • Choose the most convenient or least expensive broad-spectrum topical antibiotic for mild cases, as no clinical evidence demonstrates superiority of any particular agent 1

  • Acceptable first-line options include:

    • Polymyxin B/trimethoprim 1
    • Gentamicin 1
    • Tobramycin 1
    • Erythromycin 1
  • Reserve fluoroquinolones (moxifloxacin, gatifloxacin, levofloxacin, ciprofloxacin, besifloxacin) for moderate to severe cases with copious purulent discharge, pain, and marked inflammation, or when resistant organisms are suspected 1

  • Contact lens wearers require fluoroquinolone coverage due to higher risk of Pseudomonas infection 1

Dosing Regimens

  • Standard regimen: Apply topical antibiotic 4 times daily for 5-7 days 1, 2
  • Moxifloxacin 0.5%: Instill one drop in affected eye 3 times daily for 7 days 3
  • Moxifloxacin demonstrates clinical cure rates of 66-69% by Day 5-6 and microbiological eradication rates of 84-94% 3

Moderate to Severe Bacterial Conjunctivitis

  • Obtain conjunctival cultures and Gram staining before initiating treatment if severe purulent discharge is present or gonococcal infection is suspected 1
  • Consider brief course of topical corticosteroids if severe inflammation of conjunctiva or eyelid is present, with baseline and periodic intraocular pressure monitoring 1

Follow-Up Protocol

  • Advise patients to return in 3-4 days if no improvement is noted 4, 1
  • At follow-up, perform interval history, visual acuity measurement, and slit-lamp biomicroscopy 1
  • If no improvement after 3-4 days, consider alternative diagnoses, resistant organisms (particularly MRSA), or need for culture 1

Special Bacterial Conjunctivitis Scenarios

Gonococcal Conjunctivitis

Gonococcal conjunctivitis requires systemic antibiotic therapy in addition to topical treatment, as topical antibiotics alone are inadequate. 1

  • Systemic treatment: Ceftriaxone 125 mg IM single dose (for patients ≥45 kg) 2
  • Add saline lavage to promote comfort and faster resolution of inflammation 1
  • Daily follow-up is mandatory until resolution 2
  • Hospitalization may be necessary for severe cases 1
  • Always consider and evaluate for sexual abuse in children with gonococcal conjunctivitis 2
  • Treat sexual partners simultaneously 4

Chlamydial Conjunctivitis

Chlamydial conjunctivitis requires systemic antibiotic therapy, as more than 50% of infants may have infection at other sites (nasopharynx, genital tract, lungs). 4

  • Systemic treatment options (for patients ≥8 years):
    • Azithromycin 1 g orally, single dose, OR 2
    • Doxycycline 100 mg orally twice daily for 7 days 2
  • For neonates: Erythromycin base or ethylsuccinate 50 mg/kg/day divided into four doses daily for 14 days 1
  • No evidence supports adding topical therapy to systemic treatment 4, 1
  • Re-evaluate following treatment, as treatment failure rates can reach 19% 4
  • Treat sexual partners simultaneously and evaluate for concomitant sexually transmitted diseases 4
  • Consider sexual abuse in children with chlamydial conjunctivitis 4, 2

MRSA Conjunctivitis

  • MRSA infections may require compounded topical vancomycin, as MRSA organisms are resistant to many commercially available topical antibiotics including aminoglycosides 1
  • Bacterial resistance is an increasing concern, particularly with MRSA 1, 5

Neonatal Conjunctivitis (Birth to 28 Days)

Neonatal conjunctivitis always requires immediate treatment and evaluation due to risk of serious complications including corneal perforation, septicemia, and meningitis. 5

  • Hospitalization is mandatory for neonatal conjunctivitis 1
  • Gonococcal conjunctivitis (manifests 1-7 days after birth) requires systemic ceftriaxone 125 mg IM plus topical antibiotics 5

Viral Conjunctivitis

Viral conjunctivitis requires supportive treatment only; avoid prescribing antibiotics as this promotes unnecessary costs and antibiotic resistance. 1, 6

  • Treatment is supportive with artificial tears and cool compresses 6
  • Most cases are self-limiting 6

Allergic Conjunctivitis

Allergic conjunctivitis is treated with topical antihistamines and mast cell stabilizers; itching is the most consistent diagnostic sign. 6

  • Treatment options include:
    • Topical lubricants 7
    • Topical antihistamine agents 7
    • Systemic antihistamines 7

Mandatory Ophthalmology Referral Criteria

Refer to an ophthalmologist immediately for any of the following: 4, 1

  • Visual loss 4, 1
  • Moderate or severe pain 4, 1
  • Severe purulent discharge 4, 1
  • Corneal involvement or infiltrates 4, 1, 5
  • Conjunctival scarring 4
  • Lack of response to therapy after 3-4 days 4, 1
  • Recurrent episodes 4
  • History of HSV eye disease 4
  • History of immunocompromise 4
  • All contact lens wearers with conjunctivitis due to higher risk of complications 2

Infection Control and Patient Education

  • Hand washing is critical to reduce transmission risk 4, 5
  • Avoid sharing towels, pillows, and close contact during contagious period 2
  • Patients should not wear contact lenses if signs or symptoms of bacterial conjunctivitis are present 4, 3
  • Return to school or work is generally permitted once treatment has been initiated for 24 hours and symptoms begin to improve 5, 2

Common Pitfalls to Avoid

  • Do not prescribe antibiotics for viral conjunctivitis, which promotes resistance and unnecessary costs 1
  • Do not use topical antibiotics alone for gonococcal or chlamydial conjunctivitis—systemic therapy is mandatory 1, 2
  • Do not overlook the possibility of sexual abuse in children with gonococcal or chlamydial infections 4, 2
  • Do not use fluoroquinolones as first-line for mild cases—reserve for severe infections to minimize resistance 1
  • In neonatal intensive care settings, gram-negative conjunctivitis is often resistant to gentamicin 1

References

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Bacterial Conjunctivitis in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.